BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11756701)

  • 1. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
    Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
    J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands.
    Visser K; de Vries SO; Kitslaar PJ; van Engelshoven JM; Hunink MG
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):213-23. PubMed ID: 12623332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.
    Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis.
    Visser K; Kuntz KM; Donaldson MC; Gazelle GS; Hunink MG
    J Vasc Interv Radiol; 2003 Jan; 14(1):53-62. PubMed ID: 12525586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group.
    Bosch JL; Tetteroo E; Mali WP; Hunink MG
    Radiology; 1998 Sep; 208(3):641-8. PubMed ID: 9722840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.
    Treesak C; Kasemsup V; Treat-Jacobson D; Nyman JA; Hirsch AT
    Vasc Med; 2004 Nov; 9(4):279-85. PubMed ID: 15678620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
    Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
    J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States.
    Bosch JL; Haaring C; Meyerovitz MF; Cullen KA; Hunink MG
    AJR Am J Roentgenol; 2000 Aug; 175(2):517-21. PubMed ID: 10915706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis.
    Hunink MG; Wong JB; Donaldson MC; Meyerovitz MF; de Vries J; Harrington DP
    JAMA; 1995 Jul; 274(2):165-71. PubMed ID: 7596006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
    Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
    Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular intervention for treatment of claudication: is it cost-effective?
    O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
    Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice.
    van Asselt AD; Nicolaï SP; Joore MA; Prins MH; Teijink JA;
    Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):97-103. PubMed ID: 21159527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital.
    Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA
    Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness targets for multi-detector row CT angiography in the work-up of patients with intermittent claudication.
    Visser K; Kock MC; Kuntz KM; Donaldson MC; Gazelle GS; Hunink MG
    Radiology; 2003 Jun; 227(3):647-56. PubMed ID: 12773672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication.
    van den Houten MM; Lauret GJ; Fakhry F; Fokkenrood HJ; van Asselt AD; Hunink MG; Teijink JA
    Br J Surg; 2016 Nov; 103(12):1616-1625. PubMed ID: 27513296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
    Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.
    Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
    Radiology; 2009 Feb; 250(2):586-95. PubMed ID: 19188327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.